Middlemen, not drug companies, are pushing up insulin prices, and Congress doesn’t have the right plan to fight back
November 19, 2021 at 09:36 AM EST
Why should those who distribute insulin, such as pharmacy-benefit managers, get more than half of the money spent by consumers?
